Acute psychosis in anti-NMDA-receptor encephalitis

Presse Medicale

Volumn 40, Issue 9, 2011, Pages 882-884

  Sacré, Karim ^a   Lidove, Olivier ^a   Chanson, Noémie ^a   Laganier, Jean ^a   Vidailhet, Marie ^b   Lejoyeux, Michel ^a   Papo, Thomas ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; CIPROFLOXACIN; CREATINE KINASE; CYAMEMAZINE; FLUORODEOXYGLUCOSE F 18; HALOPERIDOL; IMMUNOGLOBULIN; LOXAPINE; METHOTREXATE; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; PREDNISONE; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; VALPROIC ACID;

ACUTE PSYCHOSIS; ADULT; AGITATION; BODY POSTURE; BRAIN DAMAGE; CASE REPORT; CATALEPSY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COGNITION; COGNITIVE REHABILITATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISORIENTATION; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EMOTIONAL DISORDER; ENCEPHALITIS; ENZYME BLOOD LEVEL; EPILEPTIC DISCHARGE; FATIGUE; FEMALE; FEVER; FOLLOW UP; GRAND MAL SEIZURE; HEADACHE; HUMAN; HYPOVENTILATION; LABORATORY TEST; LETTER; LEUKOCYTE COUNT; LOW DRUG DOSE; MEMORY DISORDER; MOOD CHANGE; MOOD DISORDER; MOTOR DYSFUNCTION; MUSCLE HYPERTONIA; NEUROLOGIC DISEASE; OROFACIAL DYSKINESIA; PHYSICAL EXAMINATION; PLEOCYTOSIS; POSITRON EMISSION TOMOGRAPHY; RECURRENT DISEASE; RELAPSE; RESPIRATORY TRACT INTUBATION; SCHIZOPHRENIA; SHORT TERM MEMORY; SOMNOLENCE; SPEECH DISORDER; THETA RHYTHM; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BRAIN DAMAGE, CHRONIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOSUPPRESSIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 80052304087     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.05.010     Document Type: Letter

References (6)

1. Dalmau J., Tuzun E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61(1):25-36.
2. Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X., Lai M., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7(12):1091-1098.
3. Lorance N.R., Davis R.L., Lam C., Szperka C., Zhou L., Ahmad S., et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66(1):11-18.
4. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999, 33(6):523-533.
5. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006, 26(4-6):365-384.
6. McAllen K.J., Schwartz D.R. Adverse drug reactions resulting in hyperthermia in the intensive care unit. Crit Care Med 2010, 38(6 Suppl):S244-252.